Ingenia Therapeutics Inc. (KOSDAQ:950260)
23,200
+3,000 (14.85%)
At close: Nov 18, 2026
Ingenia Therapeutics Revenue
Ingenia Therapeutics had revenue of 7.42B KRW in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to 7.42B. That makes Ingenia Therapeutics the 39,653rd largest company in the world by revenue and 2,478th in South Korea.
Revenue (ttm)
7.42B
Revenue Growth
n/a
P/S Ratio
134.62
Revenue / Employee
370.96M
Employees
20
Market Cap
1.15T
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 3.53B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.